Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma. [PDF]
Yan F +22 more
europepmc +1 more source
Clinical characteristics, treatment patterns, and survival in mantle cell lymphoma: a real-world cohort. [PDF]
de la Hoz C +11 more
europepmc +1 more source
Beyond the CAR-T horizon in mantle cell lymphoma. [PDF]
Lew TE, Seymour JF.
europepmc +1 more source
Blastoid Mantle Cell Lymphoma in the Leukemic Phase: Resolving a Morphological Dilemma Through Flow Cytometry. [PDF]
Kundu A, Giri S, Basu A.
europepmc +1 more source
Appendiceal Intussusception Secondary to Mantle Cell Lymphoma: A Report of a Rare Case. [PDF]
Miyata N, Asomah F.
europepmc +1 more source
KSHV- and EBV-associated germinotropic lymphoproliferative disorder [PDF]
Cabecadas, J +11 more
core +1 more source
Advances in biomarkers for mantle cell lymphoma in the era of targeted therapies. [PDF]
Loh Z, Yeh P, Keane C, Hawkes EA.
europepmc +1 more source
Multifaceted cfDNA profiling in mantle cell lymphoma. [PDF]
Sworder BJ, Herrera AF.
europepmc +1 more source
Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma. [PDF]
Pfitzer J +5 more
europepmc +1 more source
Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction [PDF]
Attygalle, AD +8 more
core +1 more source

